December 07, 2021
07/12/2021
December 07, 2021
LA JOLLA, CA The Scripps Research Digital Trials Center has launched a new research consortium aimed at improving maternal and fetal health outcomes. The PowerMom consortium brings together organizations from a broad spectrum of sectors from health and technology companies to advocacy groups and community health centers to advance research into maternal health.
PowerMom leverages innovative digital and mobile technologies to recruit, monitor and communicate with pregnant study participants. Led by researchers at the Scripps Research Digital Trials Center, the goal is to build the largest, most diverse community of pregnant people and gather valuable health information that will hopefully help guide expectant mothers and care teams toward healthier pregnancies.
The consortium will support efforts to build awareness of the study platform, encourage participation, provide wearable devices to eligible participants, and help guide scientific priorities.
A national public health crisis
The launch of the consortium comes at a pivotal moment. Maternal health in the United States remains in a state of crisis, ranking first in maternal mortality among developed nations. Despite global maternal mortality decreasing over the course of the last few decades, in the United States the rate has been increasing, with 63% of these pregnancy-related deaths being preventable.
Deep inequities across race, socioeconomic status and geography are exceedingly evident. Black, American Indian and Alaska Native mothers are two to three times more likely to die from pregnancy-related complications than their white counterparts, while Hispanic mothers have the highest rates of increase in severe maternal morbidity in recent years.
Historically, pregnant people have been excluded from most clinical research resulting in significant knowledge gaps when it comes to understanding pregnancy on an individual level, says Toluwalas Ajayi, MD, who is a physician and clinical researcher at Scripps Research, and the principal investigator of PowerMom. Staggering racial inequities make it all the more urgent for scientists to help tackle this national public health crisis.
Joining forces
Together with partners across the country, clinical researchers and data scientists at Scripps Research are approaching this challenge through a combination of innovation, crowdsourcing and community outreach. Tapping into the ubiquity of smartphones and improving broadband access, the PowerMom team has developed an app-based research platform that allows pregnant people to share health data through surveys, electronic health records and wearables such as fitness trackers and smartwatches. By enabling participants to enroll and participate in the study remotely, the scientists hope to eliminate some of the barriers that exist for traditional clinic-based studies which have historically lacked diversity. Building a large and diverse community of pregnant people will allow scientists to shed light on the unique characteristics that contribute to healthy pregnancies.
The team is partnering with organizations with a shared commitment to improving the health of mothers and babies. Outreach support will be provided by Microsoft, March of Dimes, WebMD, Mae, Happy Mama Healthy Baby Alliance, and African American Wellness Center for Children and Families all of which are helping build awareness of the study. CareEvolution, a health technology company that enables sharing of health information, developed MyDataHelps , the research platform that powers PowerMom and many other digital studies currently underway. Digital health company Sharecare will assist with the development of digital biomarkers and AI models to track maternal health conditions through Smart Omix, its decentralized clinical research platform. In addition, Woebot Health is supporting a sub-study on postpartum mental health management, and Fitbit is supporting a study on the impact that systemic racism experienced by Black and Hispanic pregnant people may have on their health.
We are incredibly fortunate to be working with an exceptional group of organizations whose support will be invaluable to our goal of building a diverse community of pregnant people and advancing research on health disparities in maternal health, says Katie Baca-Motes, director of strategic initiatives at Scripps Research.
The PowerMom consortium builds on a successful pilot phase of the study which saw more than 3,500 pregnant people share their health data with scientists. The initial findings, published in npj Digital Medicine, demonstrate the utility of a smartphone app-based research platform in enabling the recruitment of a large and diverse population of pregnant people to participate in biomedical research.
Any pregnant person living in the United States who has a smartphone is eligible to start participating today. To learn more, visit powermom.scripps.edu.
A new era of research
PowerMom is one in a portfolio of studies currently benefiting from this robust digital research platform that enables researchers and participants to gather valuable health data and translate that data into new knowledge. De-identified data can be securely analyzed by researchers, while participants gain insights into their own health. Transparency and return of information allow for a unique partnership between scientists and study participants that promotes trust because it's a bi-directional type of communication, explains Ajayi.
The team at the Digital Trials Center aims to further expand their nationwide network of partners, enabling many more studies into different aspects of maternal
LINK: | https://www.scripps.edu/news-and-events/press-room/2021/20211207-ajayi... |
See more stories from scripps |
More from Scripps
13/03/2024
March 13, 2024
New computational strategy boosts the ability of drug designers to target proteins inside the membrane Customized-design approach could streamline the design of...
29/02/2024
February 29, 2024
Scripps Research scientists reveal how first cells could have formed on Earth New phospholipid discovery brings researchers closer to understanding how primordi...
29/02/2024
February 28, 2024
How molecular handedness emerged in early biology Scripps Research chemists fill a major gap in origin-of-life theories. February 28, 2024 LA JOLLA, CA Mole...
22/02/2024
February 21, 2024
Snaking toward a universal antivenom Scripps Research scientists discovered antibodies that protect against a host of lethal snake venoms. February 21, 2024 ...
06/02/2024
February 06, 2024
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases AbbVie...
26/01/2024
January 25, 2024
Re-energizing mitochondria to treat Alzheimer's disease Scripps Research team restored neuron-to-neuron connections in human cells. January 25, 2024 LA JO...
24/01/2024
January 04, 2024
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health For the last century, institute leaders and renowned scie...
23/01/2024
January 23, 2024
New technology lets researchers track brain cells' off switches The method could shed light on what goes awry in numerous brain conditions when neurons ar...
09/01/2024
January 08, 2024
Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines The ALSAM Foundation, founded by the Skaggs family, provides lasting g...
04/01/2024
January 03, 2024
Life science entrepreneur Gene Lay joins Scripps Research Board of Directors Lay, founder of the global biotech company BioLegend, brings invaluable experience ...
21/12/2023
December 20, 2023
Taming a plant-derived toxin Scripps Research team modifies the traditional poison picrotoxinin for potential neurological drugs and anti-parasite treatments. ...
19/12/2023
December 18, 2023
Scripps Research Executive Vice President Eric Topol gives TED talk on transformative power of AI in medicine Topol provides an overview of how AI models can i...
13/12/2023
December 12, 2023
New AI-powered algorithm could better assess people's risk of common heart condition Early detection of atrial fibrillation can reduce the risk of stroke an...
07/12/2023
December 06, 2023
Nanoparticle flu vaccine design shows promise in early tests Scripps Research-designed vaccine could provide broad, enduring protection against influenza A str...
16/11/2023
November 15, 2023
Numerous Scripps Research scientists named Highly Cited Researchers Clarivate's annual, global list represents researchers who have demonstrated significant...
07/11/2023
November 06, 2023
Multiple sclerosis drug invented at Scripps Research slows long-term devastating disease progression Late-breaking data reinforces the effectiveness and safety ...
05/10/2023
October 04, 2023
Keren Lasker named a 2023 Moore Inventor Fellow The prestigious award will support Lasker's inventive research in membraneless organelles and their applica...
22/09/2023
September 21, 2023
Michael Bollong named a 2023 Amgen Young Investigator The prestigious award will support Bollong's research identifying new molecular targets and therapeuti...
09/09/2023
September 08, 2023
Philip Dawson receives 2024 American Chemical Society National Award Dawson is honored with the Arthur C. Cope Late Careers Scholar Award for his foundational c...
07/09/2023
September 06, 2023
Scripps Research chemists devise a method for C-H activation of alcohols The method represents a new toolkit for making drugs and other compounds. September 06...
31/08/2023
August 30, 2023
Scripps Research receives $1.5M to surveil infectious disease threats in wastewater Bill & Melinda Gates Foundation award to support the development of multi-pa...
16/08/2023
August 16, 2023
How cold temperatures trigger the brain to boost appetite Scripps Research scientists' discovery could lead to new weight loss and metabolic health treatmen...
08/08/2023
August 07, 2023
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study Scripps Research-developed antibody therapy...
04/08/2023
August 03, 2023
How sensory neurons impact the gut Scripps Research scientists show that the receptor PIEZO2 in sensory neurons controls gut motility and transit time, which a...
26/07/2023
July 26, 2023
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets The expanded strategic collaboration will advan...
23/07/2023
July 21, 2023
Scripps Research scientists develop AI-based tracking and early-warning system for viral pandemics Machine-learning system effectively predicts emergence of pro...
19/07/2023
July 19, 2023
Monitoring T cells may allow prevention of type 1 diabetes Scripps Research study shows that analyzing T cells in blood samples could be used to select at-risk ...
19/07/2023
July 18, 2023
Scripps Research mourns passing of leading organic chemist Albert Eschenmoser Eschenmoser pioneered key reactions in synthetic chemistry and shaped the understa...
15/06/2023
June 14, 2023
Scripps Research awarded $46.8 million by NIH to promote human health through innovative translational science and training The Translational Institute is harne...
13/06/2023
June 13, 2023
Scripps Research's Danielle Grotjahn named 2023 Pew Scholar in the Biomedical Sciences The award will support Grotjahn's study of how cells assemble the...
31/05/2023
May 31, 2023
Crossing the ring: new method enables C-H activation across saturated carbocycles Scripps Research chemists add another powerful tool to their molecular editin...
24/05/2023
May 23, 2023
Scripps Research develops behind-the-scenes tool for better biomedical data discovery The new resource makes datasets more discoverable for life science communi...
19/05/2023
May 15, 2023
Scripps Research neuroscientist Hollis Cline elected to American Academy of Arts and Sciences Cline is recognized for her discoveries about the role of sensory ...
19/05/2023
May 18, 2023
Scripps Research's Skaggs Graduate School awards doctoral degrees to 31st graduating class Commencement ceremony will be livestreamed via Zoom and on instit...
13/05/2023
May 12, 2023
A better route to benzocyclobutenes, sought-after building blocks for drugs Scripps Research chemists devise a new, C-H activation-based method for the synthesi...
09/05/2023
May 08, 2023
Renowned Scripps Research professor Jeffery Kelly elected to National Academy of Sciences Kelly's groundbreaking work on protein misfolding has led to thera...
28/04/2023
April 27, 2023
Mirror-image molecules pave new path for cancer drug discovery By comparing how mirror image versions of small molecules impact clusters of proteins, Scripps R...
22/04/2023
April 21, 2023
How alcohol consumption contributes to chronic pain A Scripps Research team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and...
21/04/2023
April 20, 2023
Xin Jin receives dual awards to study autism risk genes in neurodevelopment Major grants from the National Institutes of Health and California Institute for Reg...
20/04/2023
April 19, 2023
Trim the sugar: New HIV vaccine design improves immune response Scripps Research vaccine candidate headed for clinical trials. April 19, 2023 LA JOLLA, CA A...
18/04/2023
April 17, 2023
Therapeutic can seek and destroy potent opioid to treat overdoses Scripps Research chemists developed a new biologic to work against the synthetic opioid carfen...
07/03/2023
March 06, 2023
How heavy alcohol consumption increases brain inflammation The findings by a Scripps Research team point toward a potential new drug target for treating alcohol...
02/03/2023
March 01, 2023
Scientists find human antibodies that can block multiple coronaviruses including SARS-CoV-2 Results from a Scripps Research and UNC team pave the way for a vacc...
28/02/2023
February 28, 2023
$10 million grant funds Scripps Research Alcohol Research Center through its 50th year The five-year grant supports research into the neurobiology of alcohol us...
28/02/2023
February 27, 2023
Immune system drug shows promise in treating alcohol use disorder, a Scripps Research clinical trial reports Scientists at Scripps Research found that apremilas...
23/02/2023
February 16, 2023
Chemically poisoned protein acts as a molecular switch to spur cancer formation The discovery triggered development of a new potential drug to eliminate tumor...
23/02/2023
February 23, 2023
Two new papers demonstrate use of Outbreak.info as one-stop online source for COVID data Scripps Research scientists highlight the need for continued monitorin...
15/02/2023
February 15, 2023
Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound Calibr transitions i...
08/02/2023
February 07, 2023
Scripps Research Professor Jeffery Kelly awarded 2023 Wolf Prize in Chemistry Kelly receives the prestigious award for his seminal discoveries in protein-foldin...
31/01/2023
January 30, 2023
Experimental anti-depression drug may also be useful in treating alcohol use disorder Investigational, clinical-stage antidepressant MAP4343 shown to reduce alc...